ImageneBio (IMA) Interest & Investment Income (2021 - 2025)
ImageneBio (IMA) posted Interest & Investment Income of $1.3 million for Q2 2025, down 9.03% sequentially from $1.4 million in Q1 2025, and down 32.81% YoY from $1.9 million in Q2 2024.
ImageneBio (IMA) Interest & Investment Income (2021 - 2025) Analysis & Trends
ImageneBio has reported Interest & Investment Income for 5 years, with the latest figure at $1.3 million in Q2 2025.
- Quarterly Interest & Investment Income fell 32.81% year-over-year to $1.3 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $6.0 million (down 28.58% YoY) and the FY2024 annual result came in at $7.4 million, up 3.68% from the prior year.
- Interest & Investment Income eased to $1.3 million in Q2 2025 per IMA's latest filing, from $1.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.3 million in Q4 2023 and troughed at $5000.0 in Q4 2021.
- A 5-year average of $1.1 million and a median of $1.3 million in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 20180.0% in 2022, then slumped 32.92% in 2025.
- Over 5 years, Interest & Investment Income stood at $5000.0 in 2021, then surged by 20180.0% to $1.0 million in 2022, then jumped by 123.96% to $2.3 million in 2023, then sank by 30.96% to $1.6 million in 2024, then dropped by 17.73% to $1.3 million in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1.3 million, $1.4 million, and $1.6 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 550,000.00 |
| Jun 30, 2022 | 460,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 6,000.00 |